Could a simple patch replace wires? new study tests wearable Vital-Sign monitor
NCT ID NCT07037784
First seen Nov 20, 2025 · Last updated Jun 22, 2026 · Updated 33 times
Summary
This study will test a wearable device called OXYFLEX that sticks to the skin and tracks heart rate, breathing, temperature, oxygen levels, and hemoglobin. Researchers will compare its readings to standard hospital monitors in 102 patients from the emergency room, operating room, and intensive care unit. The goal is to see if the patch is accurate enough for everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHYSIOLOGICAL PARAMETERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HIA Ste Anne
Toulon, Var, 83000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OXYFLEX biosensor
What this could lead to
If successful, this could show that a simple wearable patch can reliably track vital signs, potentially making hospital monitoring more flexible and less intrusive.
What could go wrong
This is a small, early-stage study (102 participants) that only compares measurements over a few hours. The device may not be as accurate as standard monitors, and results may not apply to all patients or settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.